Top Markets
#1 Black Phoenix Black Phoenix +354.68%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.84%
#4 OpenEden OpenEden +62.66%
#5 Akedo Akedo +55.50%
#6 BasedHype BasedHype +26.50%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +20.20%
#9 Humanity Humanity +19.73%
#10 Ether.fi Ether.fi +17.74%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Synairgen plc Synairgen plc

Synairgen plc

SNG
Hisse Senetlerindeki Sıralama #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Hisse Fiyatı
$0.01292666
Son senkronizasyon: 2025-04-08
Piyasa Değeri
$157.54K
Değişim (1 gün)
6.84%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret Synairgen plc (SNG)

Kategori

Healthcare
Synairgen plc (SNG) için tedavüldeki hisse sayısı
June 2024 itibarıyla tedavüldeki hisse sayısı: 201.38M
Synairgen plc şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 201.38M'dir. December 2022 sonunda şirketin 201.36M tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Synairgen plc (SNG) için 2004 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
Yıl Tedavüldeki Hisse Sayısı Değiştir
2026 (TTM) 201.38M 0.00%
2023 201.38M 0.01%
2022 201.36M 0.46%
2021 200.44M 36.24%
2020 147.12M 33.64%
2019 110.09M 15.56%
2018 95.26M 1.15%
2017 94.18M 2.48%
2016 91.90M 0.64%
2015 91.32M 3.77%
2014 88.00M 16.35%
2013 75.64M 4.37%
2012 72.47M 19.66%
2011 60.56M 0.77%
2010 60.10M 154.94%
2009 23.57M 8.03%
2008 21.82M -9.98%
2007 24.24M 1.94%
2006 23.78M 26.20%
2005 18.84M 85.90%
2004 10.14M 0.00%
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
Şirket Tedavüldeki Hisse Sayısı Fark Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 26.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -69.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE